Data completeness
1/8 — Limited
UNISOM (doxylamine succinate) by Pfizer. Approved for nausea and vomiting of pregnancy.
Drug data last refreshed 1w ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
UNISOM (doxylamine succinate) is an oral small-molecule capsule indicated for nausea and vomiting of pregnancy (NVP). Doxylamine is a first-generation antihistamine that crosses the blood-brain barrier to provide symptomatic relief. This Pfizer NDA product is currently in pre-launch phase.
Pre-Launch
Pre-launch stage indicates active commercial team building and market preparation activities with near-term revenue potential.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on UNISOM at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.